Israeli 3D printed electronics company Nano Dimension Ltd., Electronics (NASDAQ, TASE: NNDM) has spun-off its bio-printing activities into a new subsidiary. Following initial successful bio-printing trials, the new subsidiary will conduct R&D in this field. As previously reported by the company, Nano Dimension's current capital will not be used for the bio-printing activities.
In May Nano Dimension announced a successful proof of concept for 3D printing of bio-ink containing stem cells. The feasibility tests demonstrated the potential to print tissues derived from viable stem cells in a process using 3D printer inkjet technology developed by Nano Dimension.
Several companies have recently expressed interest in Nano Dimension's bio-printing technology, as a result, the board of directors of the company has approved the transition of this activity to a new entity.
IDTechEx forecasts the market for 3D bio-printing will grow rapidly over the next decade from $481 million in 2014 to as much as $6 billion by 2024.
Nano Dimension, founded in 2012, focuses on development of advanced 3D printed electronics systems and advanced additive manufacturing with products that combine three advanced technologies: 3D inkjet, 3D software and nanomaterials. The company's main products include the first 3D printer dedicated to printing multi-layer PCBs (printed circuit boards) and advanced nanotechnology-based conductive and dielectric inks.
After raising $12 million in a Nasdaq offering, the Ness Ziona based company has a market cap of $69 million.
Published by Globes [online], Israel business news - www.globes-online.com - on October 10, 2016
© Copyright of Globes Publisher Itonut (1983) Ltd. 2016